This inventor holds 1 USPTO granted patent. Top assignee: Fcb-Pharmicell Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Ki Ho Park: Innovator in Adenosine Deaminase Inhibition
Introduction
Ki Ho Park is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of adenosine deaminase inhibitors. His work has implications for antibacterial and anticancer therapies, showcasing the potential of his innovations.
Latest Patents
Ki Ho Park holds 1 patent related to an adenosine deaminase inhibitor. This invention involves a novel strain, IADA-7, which produces the inhibitor. The adenosine deaminase inhibitor developed by Park demonstrates superior antibacterial and anticancer activities compared to previously reported inhibitors, marking a significant advancement in therapeutic options.
Career Highlights
Ki Ho Park is associated with Fcb-Pharmicell Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on enhancing the efficacy of treatments through the development of novel compounds.
Collaborations
Some of his coworkers include Hong Ki Jun and Young Hwan Ahn, who contribute to the collaborative efforts in research and development at Fcb-Pharmicell Co., Ltd.
Conclusion
Ki Ho Park's contributions to the field of adenosine deaminase inhibition highlight his role as an innovator in biochemistry. His work not only advances scientific knowledge but also has the potential to improve therapeutic strategies for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile